Legis Daily

Expressing support for the designation of March as "Multiple System Atrophy Awareness Month" to strengthen public awareness of this neurodegenerative disorder.

USA119th CongressHRES-1117| House 
| Updated: 3/16/2026
Kevin Mullin

Kevin Mullin

Democratic Representative

California

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This resolution expresses the House of Representatives' support for designating March as "Multiple System Atrophy Awareness Month" to strengthen public understanding of this rare and often fatal neurodegenerative disorder. It highlights that Multiple System Atrophy (MSA) affects thousands of people, causes severe physical impairments, and is frequently misdiagnosed due to a lack of awareness and its unknown cause. The resolution emphasizes that there is currently no cure or effective treatment for MSA, and insufficient public awareness hinders research efforts. Therefore, it advocates for increased public support and significant investments in research to facilitate a better understanding of the disease and accelerate the development of therapeutics and treatments.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 16, 2026
Submitted in House
Mar 16, 2026
Referred to the House Committee on Energy and Commerce.
  • March 16, 2026
    Submitted in House


  • March 16, 2026
    Referred to the House Committee on Energy and Commerce.

Expressing support for the designation of March as "Multiple System Atrophy Awareness Month" to strengthen public awareness of this neurodegenerative disorder.

USA119th CongressHRES-1117| House 
| Updated: 3/16/2026
This resolution expresses the House of Representatives' support for designating March as "Multiple System Atrophy Awareness Month" to strengthen public understanding of this rare and often fatal neurodegenerative disorder. It highlights that Multiple System Atrophy (MSA) affects thousands of people, causes severe physical impairments, and is frequently misdiagnosed due to a lack of awareness and its unknown cause. The resolution emphasizes that there is currently no cure or effective treatment for MSA, and insufficient public awareness hinders research efforts. Therefore, it advocates for increased public support and significant investments in research to facilitate a better understanding of the disease and accelerate the development of therapeutics and treatments.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 16, 2026
Submitted in House
Mar 16, 2026
Referred to the House Committee on Energy and Commerce.
  • March 16, 2026
    Submitted in House


  • March 16, 2026
    Referred to the House Committee on Energy and Commerce.
Kevin Mullin

Kevin Mullin

Democratic Representative

California

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted